Singapore markets closed

  • Straits Times Index

    3,394.21
    +17.02 (+0.50%)
     

  • Nikkei

    27,382.56
    +19.81 (+0.07%)
     

  • Hang Seng

    22,688.90
    +122.12 (+0.54%)
     

  • FTSE 100

    7,765.15
    +4.04 (+0.05%)
     

  • BTC-USD

    23,095.03
    -26.46 (-0.11%)
     

  • CMC Crypto 200

    526.66
    +9.65 (+1.87%)
     

  • S&P 500

    4,070.56
    +10.13 (+0.25%)
     

  • Dow

    33,978.08
    +28.67 (+0.08%)
     

  • Nasdaq

    11,621.71
    +109.30 (+0.95%)
     

  • Gold

    1,943.90
    -2.80 (-0.14%)
     

  • Crude Oil

    79.38
    -1.63 (-2.01%)
     

  • 10-Yr Bond

    3.5180
    +0.0250 (+0.72%)
     

  • FTSE Bursa Malaysia

    1,497.55
    -0.84 (-0.06%)
     

  • Jakarta Composite Index

    6,898.98
    +34.16 (+0.50%)
     

  • PSE Index

    7,052.16
    +9.46 (+0.13%)
     

Zimmer Biomet (ZBH) Q3 Earnings Beat, Gross Margin Falls

Zacks Equity Research
·4-min read

Zimmer Biomet Holdings, Inc. ZBH posted third-quarter 2022 adjusted earnings per share (EPS) of $1.58, beating the Zacks Consensus Estimate by 1.3%. The adjusted figure however declined 7.6% year over year.

The quarter’s adjustments included certain amortization, restructuring and quality remediation-related charges, among others.

On a reported basis, the company registered earnings of 92 cents per share, a 19.4% rise from a year ago.

Revenue Details

Third-quarter net sales of $1.67 billion dropped 0.9% (up 5% at constant exchange rate or CER) year over year. The figure beat the Zacks Consensus Estimate by 2.5%.

Geographic Details

During the third quarter, sales generated in the United States totaled $973 million (up 3.2% year over year at CER) while the same in International grossed $696.8 million (up 7.3% year over year at CER).

Segments

In terms of product categories, post the dental and spine arm sell-off, the company continues to report through the remaining four product categories.

Sales in the Knees unit improved 7.2% year over year at CER to $657 million. Hips recorded a 10.5% rise at CER to $468 million. Revenues in the S.E.T. (Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic) unit declined 2.1% year over year to $409.4 million.

Zimmer Biomet Holdings, Inc. Price, Consensus and EPS Surprise

Zimmer Biomet Holdings, Inc. Price, Consensus and EPS Surprise
Zimmer Biomet Holdings, Inc. Price, Consensus and EPS Surprise

Zimmer Biomet Holdings, Inc. price-consensus-eps-surprise-chart | Zimmer Biomet Holdings, Inc. Quote

Other revenues fell 0.4% to $135.4 million.

Earlier the company noted that its CMFT (Craniomaxillofacial and Thoracic) products, previously reported in the Dental, Spine & CMFT category, are now included in the S.E.T. category.

Margins

Gross margin, after excluding intangible asset amortization, was 70.8%, reflecting a contraction of 8 basis points (bps) in the third quarter. Selling, general and administrative expenses were down 4.3% to $654.9 million. Research and development expenses rose 8.4% to $101.7 million. Adjusted operating margin expanded 78 bps to 25.5% in the quarter.

Cash Position

Zimmer Biomet exited the third quarter of 2022 with cash and cash equivalents of $545.4 million compared with $386.4 million at the end of the second quarter of 2022.

Cumulative net cash provided by operating activities at the end of the second quarter was $1.11 billion compared with $1.07 billion in the year-ago period.

2022 Guidance

Zimmer Biomet updated its financial guidance for 2022.

Revenues are expected to be flat to up 1% (an improvement from the earlier band of down 1% to up 1%) compared with 2021.

Adjusted EPS guidance for the full year was narrowed to the range of $6.80-$6.90 (from the projection of $6.70-$6.90 earlier).

The Zacks Consensus Estimate for 2022 adjusted earnings is pegged at $6.79 on revenues of $6.84 billion.

Our Take

Zimmer Biomet ended the third quarter of 2022 with better-than-expected earnings and revenues. Each of the company’s geographic segments and product divisions, barring S.E.T. and “Other” recorded year-over-year sales growth at CER. An updated adjusted EPS guidance above the Zacks Consensus Estimate buoys optimism.

Yet, amid the challenging macroeconomic condition, reported revenues and adjusted EPS dropped on a year-over-year basis. However, a contraction in the company’s gross margins is concerning.

Zacks Rank and Key Picks

Zimmer Biomet currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader medical space that have announced quarterly results are Elevance Health Inc. ELV, Medpace Holdings, Inc. MEDP and Merit Medical Systems, Inc. MMSI.

Elevance Health, carrying a Zacks Rank #2 (Buy), reported third-quarter 2022 adjusted EPS of $7.53, which beat the Zacks Consensus Estimate by 6.1%. Revenues of $39.63 billion outpaced the consensus mark by 1.3%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Elevance Health has an estimated long-term growth rate of 12%. ELV’s earnings surpassed estimates in all the trailing four quarters, the average being 4.1%.

Medpace Holdings, sporting a Zacks Rank #1, reported third-quarter 2022 EPS of $2.05, which beat the Zacks Consensus Estimate by 39.5%. Revenues of $383.7 million outpaced the consensus mark by 8.1%.

Medpace Holdings has an estimated growth rate of 44.9% for the full-year 2022. MEDP’s earnings surpassed estimates in all the trailing four quarters, the average being 22%.

Merit Medical, flaunting a Zacks Rank #1, reported third-quarter 2022 adjusted EPS of 64 cents, which beat the Zacks Consensus Estimate by 20.8%. Revenues of $287.2 million outpaced the consensus mark by 5.2%.

Merit Medical has an estimated long-term growth rate of 11%. MMSI’s earnings surpassed estimates in all the trailing four quarters, the average being 25.4%.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Merit Medical Systems, Inc. (MMSI) : Free Stock Analysis Report
 
Zimmer Biomet Holdings, Inc. (ZBH) : Free Stock Analysis Report
 
Medpace Holdings, Inc. (MEDP) : Free Stock Analysis Report
 
Elevance Health, Inc. (ELV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Latest stories

  • Elektros Begins Feasibility Study on Lithium Mining Project in Sierra Leon

    Elektros (OTC PINK:ELEK), an emerging leader in the electric mobility industry, announced it has begun talks with Lithium mining project in Sierra Leon, Africa.

  • India's Adani slammed by $48 billion stock rout, clouding record share sale

    Seven listed companies of the Adani conglomerate - controlled by one of the world's richest men Gautam Adani - have lost a combined $48 billion in market capitalisation since Wednesday, with U.S. bonds of Adani firms also falling after Hindenburg Research flagged concerns in a Jan. 24 report about debt levels and the use of tax havens. "With the current market price below the FPO offer price, it further puts doubts on issue subscription."

  • Bishopsgate Residences penthouse gets $1.1 mil makeover

    View of the living area from the study loft of the penthouse of the newly refurbished penthouse at Bishopsgate Residences (Photo: SuMisura)SINGAPORE (EDGEPROP) - Leading interior design firm SuMisura recently completed an extensive renovation of a 6,082 sq ft, four-bedroom penthouse at Bishopsgate Residences. The 31-unit, freehold luxury condominium was developed by Japanese developer Kajima Corp, and completed in November 2012.The new owner of the penthouse, believed to be a Chinese national wh

  • HDB resale prices increased 10.4% last year, moderating from a 12.7% price gain in 2021

    HDB flats along Whampoa River. The next BTO sales exercise next month will offer 4,400 flats and will comprise new developments in Jurong West, Kallang Whampoa, Queenstown, and Tengah.Based on the latest quarterly HDB price statistics released on Jan 27, flat resale prices increased by 2.3% q-o-q in 4Q2022. This brings the total price increase for 2022 to 10.4% compared to the 12.7% price gain recorded in 2021.This also marks the fourth consecutive annual increase in HDB resale prices since 2019

  • Singapore home prices grow the Least since 2020 as boom eases

    Singapore home prices grew at the slowest pace in more than two years in the fourth quarter of 2022, a sign that the property boom is starting to moderate as supply dwindles and interest rates climb.

  • Singapore celebrates wettest Lunar New Year in at least a decade

    Tourists visiting Singapore for the Lunar New Year have been greeted with wet weather and plunging temperatures that have locals scratching their heads as the city state records the most rainfall in at least a decade.

  • India cenbank governor says current account deficit manageable

    India's current account deficit is "eminently manageable" and within the parameters of viability, India's central bank governor Shaktikanta Das said at an event on Friday. The net balance under services and remittances remains in a large surplus, partly offsetting the trade deficit, Das said at a conference in Dubai, according to a copy of the speech released by the central bank. While the global environment has turned hostile and uncertain, the Indian economy remains resilient, said Das, pointing to a strong financial system in the country and deleveraged corporate balance sheets.

  • Indian dealers offer hefty discounts as high prices dent sales

    Physical gold dealers in India offered the steepest discounts in 10 months this week to lure customers, as a sharp rally in local prices squeezed demand in the world's second-biggest bullion consumer. Local gold prices hit an all-time high of 57,125 rupees ($700.02) per 10 grams this week, forcing dealers to offer discounts of as much as $42 an ounce over official domestic prices, inclusive of 15% import and 3% sales levies, versus a discount of $24 last week. Dealers and jewellers have been postponing purchases on hopes the government would cut import duty in the upcoming budget, said a Mumbai-based dealer with a private bullion importing bank.

  • IMF announces visit to crisis-hit Pakistan

    The IMF will send a team to Pakistan next week to discuss reviving a desperately needed bailout programme, with a foreign exchange crisis bringing imports almost to a standstill. But Khan reneged on his promise to cut subsidies and market interventions that had cushioned the cost-of-living crisis, causing the programme to stall.

  • Surbana Jurong Group ranked 13th largest architecture firm globally

    The WA100 2023 ranking follows a number of awards received by the group, including the HDB Design Award 2022 for Northshore StraitsView (pictured here) (Picture: Surbana Jurong)SINGAPORE (EDGEPROP) - Surbana Jurong Group is the 13th largest architecture and design firm in the world, according to the World Architecture 100 (WA100) 2023. The WA100 survey, annually published by architectural magazine Building Design, ranks the world’s largest architecture practices by the number of fee-earning arch

  • Singapore property market continues to have high prospects for UHNWIs

    With political stability, high economic growth, Singapore property market continues to be a safe haven for UHNWIs to store their wealth. The post Singapore property market continues to have high prospects for UHNWIs appeared first on iCompareLoan.

  • Exclusive-Indian sugar mills to close early as rain hits cane supply - govt official

    MUMBAI (Reuters) -Sugar mills in India's top producing state Maharashtra are set to stop cane crushing 45 to 60 days earlier than last year as heavy rain has curtailed sugar cane availability, a senior state government official told Reuters on Friday. The western state of Maharashtra, which accounts for more than a third of the country's sugar output, could produce 12.8 million tonnes of sugar in the 2022/23 marketing year that began on Oct. 1, down from an earlier forecast of 13.8 million tonnes, Maharashtra's sugar commissioner Shekhar Gaikwad said. Lower sugar output could prevent the world's second-biggest exporter from allowing additional exports, potentially supporting global prices and allowing rivals Brazil and Thailand to increase their shipments.

  • India’s foreign exchange reserves rise to near 6-month high

    India's foreign exchange reserves rose to a near six-month high of $573.7 billion in the week through Jan. 20, the Reserve Bank of India's (RBI) statistical supplement showed on Friday. This, coupled with valuation changes, adds to the central bank's forex reserves.

  • Oil prices settle lower on stronger supply outlook

    (Reuters) -Oil prices settled lower on Friday, making their weekly finish flat to lower, as indications of strong Russian oil supply offset better-than-expected U.S. economic growth data, strong middle distillate refining margins and hopes of a rapid recovery in Chinese demand. Oil loadings from Russia's Baltic ports are set to rise by 50% this month from December as sellers try to meet strong demand in Asia and benefit from rising global energy prices, traders said and Reuters calculations showed.

  • Residential property prices rise for 11 consecutive quarters

    Residential property prices of both private properties and HDB resale flats, have risen for 11 consecutive quarters show Government data. The post Residential property prices rise for 11 consecutive quarters appeared first on iCompareLoan.

  • Adani rout crosses US$50 bil as stocks plunge by daily limits

    Adani Enterprises lost more than 19% on Friday, sliding below the 3,276 rupees ($52.74) level.

  • Column-India’s low coal stocks threaten electricity supply: Kemp

    India’s power generators have struggled to rebuild coal stocks so far this winter because consumption is rising faster than the rail network can deliver more fuel from the mines. Fuel stocks are only slightly higher than this time last year, when inadequate coal supplies coupled with higher than normal temperatures in March and April contributed to widespread blackouts. Stocks at power producers are equivalent to less than 12 days of consumption, up from 9 days this time last year but much leaner than 18 days in 2021 and 19 days in 2020.

  • UOB Kay Hian upgrades Frencken to 'buy' due to 'positive outlook' for its key customer and improving cost pressures

    UOB Kay Hian's John Cheong has increased his target price to $1.36 from $1.07 previously.

  • Seeking Shelter from Interest Rate Increases? These 4 Singapore Companies Should Do the Trick

    If you’re worried that higher interest rates may negatively impact your investments, here are four stocks you can consider accumulating. The post <strong>Seeking Shelter from Interest Rate Increases? These 4 Singapore Companies Should Do the Trick</strong> appeared first on The Smart Investor.

  • Radisson Hotel Group enters 2023 with strong foundation for growth following signings, openings, and market entrances in 2022

    Radisson Hotel Group has paved the way for a strong 2023 by strengthening its foothold in Asia Pacific, doubling the number of signings in 2022, celebrating new openings, and announcing market entrances. Last year, growth in priority markets was spearheaded by highly localized strategies which included the establishment of dedicated Business Units with on-the-ground teams to enhance support for the Group's owners and partners in their time zones and local languages.